Literature DB >> 31089204

Identification of Glutaminyl Cyclase isoenzyme isoQC as a regulator of SIRPα-CD47 axis.

Zhiqiang Wu1, Linjun Weng1, Tengbo Zhang1, Hongling Tian1, Lan Fang1, Hongqi Teng1, Wen Zhang1, Jing Gao2, Yun Hao1, Yaxu Li1, Hu Zhou2, Ping Wang3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31089204      PMCID： PMC6796872          DOI： 10.1038/s41422-019-0177-0

Source DB:  PubMed          Journal:  Cell Res        ISSN： 1001-0602            Impact factor:   25.617


× No keyword cloud information.
  10 in total

1.  Inhibition of glutaminyl cyclase attenuates cell migration modulated by monocyte chemoattractant proteins.

Authors:  Yi-Ling Chen; Kai-Fa Huang; Wen-Chih Kuo; Yan-Chung Lo; Yu-May Lee; Andrew H-J Wang
Journal:  Biochem J       Date:  2012-03-01       Impact factor: 3.857

2.  A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia.

Authors:  Helen E Speedy; Maria Chiara Di Bernardo; Georgina P Sava; Martin J S Dyer; Amy Holroyd; Yufei Wang; Nicola J Sunter; Larry Mansouri; Gunnar Juliusson; Karin E Smedby; Göran Roos; Sandrine Jayne; Aneela Majid; Claire Dearden; Andrew G Hall; Tryfonia Mainou-Fowler; Graham H Jackson; Geoffrey Summerfield; Robert J Harris; Andrew R Pettitt; David J Allsup; James R Bailey; Guy Pratt; Chris Pepper; Chris Fegan; Richard Rosenquist; Daniel Catovsky; James M Allan; Richard S Houlston
Journal:  Nat Genet       Date:  2013-12-01       Impact factor: 38.330

Review 3.  The blockade of immune checkpoints in cancer immunotherapy.

Authors:  Drew M Pardoll
Journal:  Nat Rev Cancer       Date:  2012-03-22       Impact factor: 60.716

4.  IsoQC (QPCTL) knock-out mice suggest differential substrate conversion by glutaminyl cyclase isoenzymes.

Authors:  Andreas Becker; Rico Eichentopf; Reinhard Sedlmeier; Alexander Waniek; Holger Cynis; Birgit Koch; Anett Stephan; Christoph Bäuscher; Stephanie Kohlmann; Torsten Hoffmann; Astrid Kehlen; Sabine Berg; Ernst-Joachim Freyse; Alexander Osmand; Anne-Christine Plank; Steffen Roßner; Stephan von Hörsten; Sigrid Graubner; Hans-Ulrich Demuth; Stephan Schilling
Journal:  Biol Chem       Date:  2016-01       Impact factor: 3.915

Review 5.  The interaction between signal regulatory protein alpha (SIRPα) and CD47: structure, function, and therapeutic target.

Authors:  A Neil Barclay; Timo K Van den Berg
Journal:  Annu Rev Immunol       Date:  2013-11-06       Impact factor: 28.527

6.  Isolation and characterization of CD47 glycoprotein: a multispanning membrane protein which is the same as integrin-associated protein (IAP) and the ovarian tumour marker OA3.

Authors:  W J Mawby; C H Holmes; D J Anstee; F A Spring; M J Tanner
Journal:  Biochem J       Date:  1994-12-01       Impact factor: 3.857

7.  Amyloidogenic processing of amyloid precursor protein: evidence of a pivotal role of glutaminyl cyclase in generation of pyroglutamate-modified amyloid-beta.

Authors:  Holger Cynis; Eike Scheel; Takaomi C Saido; Stephan Schilling; Hans-Ulrich Demuth
Journal:  Biochemistry       Date:  2008-06-21       Impact factor: 3.162

8.  Isolation of an isoenzyme of human glutaminyl cyclase: retention in the Golgi complex suggests involvement in the protein maturation machinery.

Authors:  Holger Cynis; Jens-Ulrich Rahfeld; Anett Stephan; Astrid Kehlen; Birgit Koch; Michael Wermann; Hans-Ulrich Demuth; Stephan Schilling
Journal:  J Mol Biol       Date:  2008-04-15       Impact factor: 5.469

9.  Paired receptor specificity explained by structures of signal regulatory proteins alone and complexed with CD47.

Authors:  Deborah Hatherley; Stephen C Graham; Jessie Turner; Karl Harlos; David I Stuart; A Neil Barclay
Journal:  Mol Cell       Date:  2008-07-25       Impact factor: 17.970

10.  Alternative 3' UTRs act as scaffolds to regulate membrane protein localization.

Authors:  Binyamin D Berkovits; Christine Mayr
Journal:  Nature       Date:  2015-04-20       Impact factor: 49.962
  10 in total
  11 in total

Review 1.  Macrophage-Based Combination Therapies as a New Strategy for Cancer Immunotherapy.

Authors:  Lin Tian; Anhua Lei; Tianyu Tan; Mengmeng Zhu; Li Zhang; Haibo Mou; Jin Zhang
Journal:  Kidney Dis (Basel)       Date:  2021-09-28

2.  Malaria parasite evades mosquito immunity by glutaminyl cyclase-mediated posttranslational protein modification.

Authors:  Surendra Kumar Kolli; Alvaro Molina-Cruz; Tamasa Araki; Fiona J A Geurten; Jai Ramesar; Severine Chevalley-Maurel; Hans J Kroeze; Sascha Bezemer; Clarize de Korne; Roxanne Withers; Nadia Raytselis; Angela F El Hebieshy; Robbert Q Kim; Matthew A Child; Soichiro Kakuta; Hajime Hisaeda; Hirotaka Kobayashi; Takeshi Annoura; Paul J Hensbergen; Blandine M Franke-Fayard; Carolina Barillas-Mury; Ferenc A Scheeren; Chris J Janse
Journal:  Proc Natl Acad Sci U S A       Date:  2022-08-22       Impact factor: 12.779

3.  Loss of the intracellular enzyme QPCTL limits chemokine function and reshapes myeloid infiltration to augment tumor immunity.

Authors:  Rosa Barreira da Silva; Ricardo M Leitao; Ximo Pechuan-Jorge; Scott Werneke; Jason Oeh; Vincent Javinal; Yingyun Wang; Wilson Phung; Christine Everett; Jim Nonomiya; David Arnott; Cheng Lu; Yi-Chun Hsiao; James T Koerber; Isidro Hötzel; James Ziai; Zora Modrusan; Thomas H Pillow; Merone Roose-Girma; Jill M Schartner; Mark Merchant; Sascha Rutz; Céline Eidenschenk; Ira Mellman; Matthew L Albert
Journal:  Nat Immunol       Date:  2022-03-21       Impact factor: 31.250

Review 4.  Progress of CD47 immune checkpoint blockade agents in anticancer therapy: a hematotoxic perspective.

Authors:  Yu-Chi Chen; Wei Shi; Jia-Jie Shi; Jin-Jian Lu
Journal:  J Cancer Res Clin Oncol       Date:  2021-10-05       Impact factor: 4.553

5.  Repurposing FDA-Approved Compounds for the Discovery of Glutaminyl Cyclase Inhibitors as Drugs Against Alzheimer's Disease.

Authors:  Chenshu Xu; Haoman Zou; Xi Yu; Yazhou Xie; Jiaxin Cai; Qi Shang; Na Ouyang; Yinan Wang; Pan Xu; Zhendan He; Haiqiang Wu
Journal:  ChemistryOpen       Date:  2020-12-30       Impact factor: 2.630

6.  MiR-205-5p/GGCT Attenuates Growth and Metastasis of Papillary Thyroid Cancer by Regulating CD44.

Authors:  Han-Ning Li; Hui-Min Zhang; Xing-Rui Li; Jun Wang; Tao Xu; Shu-Yu Li; Meng-Lu Dong; Ge Wang; Xiao-Qing Cui; Xue Yang; Yong-Lin Wu; Xing-Hua Liao; Ya-Ying Du
Journal:  Endocrinology       Date:  2022-04-01       Impact factor: 4.736

Review 7.  Targeting Myeloid Checkpoint Molecules in Combination With Antibody Therapy: A Novel Anti-Cancer Strategy With IgA Antibodies?

Authors:  Chilam Chan; Marta Lustig; Niklas Baumann; Thomas Valerius; Geert van Tetering; Jeanette H W Leusen
Journal:  Front Immunol       Date:  2022-07-05       Impact factor: 8.786

Review 8.  Targeting the CD47-SIRPα Innate Immune Checkpoint to Potentiate Antibody Therapy in Cancer by Neutrophils.

Authors:  Leonie M Behrens; Timo K van den Berg; Marjolein van Egmond
Journal:  Cancers (Basel)       Date:  2022-07-11       Impact factor: 6.575

9.  Myeloid checkpoint blockade improves killing of T-acute lymphoblastic leukemia cells by an IgA2 variant of daratumumab.

Authors:  Niklas Baumann; Christian Arndt; Judith Petersen; Marta Lustig; Thies Rösner; Katja Klausz; Christian Kellner; Miriam Bultmann; Lorenz Bastian; Fotini Vogiatzi; Jeanette H W Leusen; Renate Burger; Denis M Schewe; Matthias Peipp; Thomas Valerius
Journal:  Front Immunol       Date:  2022-08-16       Impact factor: 8.786

Review 10.  Regulation of CD47 expression in cancer cells.

Authors:  Can-Yu Huang; Zi-Han Ye; Mu-Yang Huang; Jin-Jian Lu
Journal:  Transl Oncol       Date:  2020-09-10       Impact factor: 4.243
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.